ACCC’s loss in Pfizer misuse of market power case to stand

Allens 2018-10-19 2:27 pm By Cat Fredenburgh | Melbourne

Please login to bookmark

The High Court has dismissed the ACCC’s bid to appeal a Full Federal Court decision upholding a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au